Orchid Pharma consolidated net profit rises 212.23% in the June 2024 quarter
Sales rise 33.62% to Rs 244.41 crore
Net profit of Orchid Pharma rose 212.23% to Rs 29.35 crore in the quarter ended June 2024 as against Rs 9.40 crore during the previous quarter ended June 2023. Sales rose 33.62% to Rs 244.41 crore in the quarter ended June 2024 as against Rs 182.92 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales244.41182.92 34 OPM %13.2912.10 -PBDT36.5618.48 98 PBT28.1210.78 161 NP29.359.40 212Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 13 2024 | 7:29 AM IST